表紙
市場調查報告書
商品編碼
1032937

全球流式細胞術市場(~2026):產品(分析儀/分選機/試劑/耗材/軟件),技術,應用(研究/臨床(癌症診斷/血液)),最終用戶(學術機構/研究實驗室/製藥公司/生物技術公司/醫院),按地區

Flow Cytometry Market by Product (Analyzer, Sorter, Reagents, Consumables, Software), Technology, Application (Research, Clinical - Cancer Diagnostics, Hematology), End User (Academia, Research Labs, Pharma, Biotech, Hospitals) - Global Forecast -2026

出版日期: | 出版商: MarketsandMarkets | 英文 273 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

在預測期內,全球流式細胞術市場預計將以 8.1% 的複合年增長率增長,從 2021 年的 43 億美元增長到 2026 年的 63 億美元。

流式細胞儀的技術進步,流式細胞術在研究和臨床試驗中的應用增加,對免疫學和免疫腫瘤學研究的關注增加,人工智能平台在工作流程和流式細胞術中的應用增加 諸如度量軟件的進步、高發生率等因素和目標疾病的流行以及新產品的可用性正在推動市場的增長。

從技術角度來看,基於細胞的技術將在 2020 年顯示出很高的份額,但基於珠子的技術預計在預測期內將以最大的複合年增長率增長。我們認為,基於微珠的部門的增長是由於與基於細胞的技術相比,它能夠檢測多種分析物(多重),具有高重現性、穩定性和速度等優勢。

本報告探索全球流式細胞儀市場,定義和概述市場,分析新型冠狀病毒感染(COVID-19)和其他市場影響因素、監管環境和專利趨勢。市場規模轉型/預測、技術/產品和服務/應用程序/最終用戶/地區/主要國家等,按類別、競爭環境、主要公司簡介等細分。

第 1 章介紹

第二章調查方法

第 3 章執行摘要

第 4 章重要考慮事項

第 5 章市場概覽

  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 挑戰
  • COVID-19 的影響
  • 監管評估
  • 專利分析
  • 供應鏈分析
  • 價值鏈分析
  • 生態系統分析
  • 波特五力分析
  • 影響客戶的趨勢
  • 範圍/場景
  • 交易數據

第 6 章流式細胞術市場:按技術

  • 細胞基礎
  • 珠座

第 7 章流式細胞術市場:按產品/服務

  • 試劑/耗材
  • 設備
    • 細胞分析儀
    • 細胞分選機
  • 服務
  • 軟件
  • 配件

第 8 章流式細胞術市場:按應用

  • 研究
    • 製藥/生物技術
    • 免疫力
    • 細胞分選
    • 細胞凋亡
    • 細胞週期分析
    • 細胞活力
    • 細胞計數
    • 其他
  • 臨床
    • 癌症診斷
    • 自身免疫性疾病
    • 器官/組織移植
    • 其他
  • 行業

第 9 章流式細胞術市場:按最終用戶

  • 學術機構/研究機構
  • 醫院/臨床實驗室
  • 製藥和生物技術公司

第 10 章流式細胞術市場:按地區

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第11章競爭形勢

  • 大公司的成功戰略
  • 市場份額分析
  • 企業評估象限
  • 競爭領導力圖:初創企業/中小企業
  • 競爭基準
  • 競爭場景/趨勢

第12章公司簡介

  • 主要公司
    • BECTON, DICKINSON AND COMPANY
    • DANAHER CORPORATION
    • THERMO FISHER SCIENTIFIC, INC.
    • AGILENT TECHNOLOGIES, INC.
    • SONY BIOTECHNOLOGY INC.
    • BIO-RAD LABORATORIES, INC.
    • MILTENYI BIOTEC
    • ENZO BIOCHEM, INC.
    • SYSMEX CORPORATION
    • BIOMERIEUX SA
    • CYTONOME/ST, LLC.
    • SARTORIUS AG
    • CYTEK BIOSCIENCES
    • UNION BIOMETRICA, INC.
    • LUMINEX CORPORATION
  • 新興企業
    • APOGEE FLOW SYSTEMS LTD.
    • STRATEDIGM, INC.
    • NANOCELLECT BIOMEDICAL, INC.
    • ON-CHIP BIOTECHNOLOGIES CO., LTD.
    • NEXCELOM BIOSCIENCE LLC.
    • BENNUBIO INC.
    • ORFLO TECHNOLOGIES
    • BAY BIOSCIENCE CO., LTD.
    • CYTOBUOY B.V.
    • BIOLEGEND, INC.

第13章 附錄

目錄
Product Code: BT 6015

The global flow cytometry market size is projected to reach USD 6.3 billion by 2026 from USD 4.3 billion in 2021, growing at a CAGR of 8.1% from 2020 to 2026. The key factors driving the growth of this market include technological advancements in flow cytometers, the increasing adoption of flow cytometry in research and clinical trials, growing focus on immunology and immuno-oncology research, increasing incorporation of AI platforms in flow cytometry workflows and advancements in flow cytometry software, high incidence and prevalence of target diseases, and the availability of novel products.

"By technology, the bead-based technology accounted for the fastest-growing segment of the flow cytometry market"

By technology, the flow cytometry market is classified into cell-based and bead-based. In 2020, the cell-based flow cytometry segment accounted for the largest share of the market. However, the bead-based flow cytometry segment is expected to grow at the highest CAGR during the forecast period. The growth of the bead-based flow cytometry segment can be attributed to the procedural advantages offered by this technology over other cell-based technology, such as the capacity to detect multiple analytes (also known as multiplexing), high reproducibility, stability, and speed.

"By product & service, the reagents and consumables segment accounted for the fastest-growing segment of the flow cytometry market."

On the basis of product and service, the flow cytometry market is categorized into reagents and consumables, instruments, services, software, and accessories. The reagents and consumables segment is expected to witness the highest growth during the forecast period due to the development and commercialization of high-quality application-specific reagents and assays and continuous requirement of flow cytometry reagents by end users (due to the increasing number of flow cytometry-based research activities).

"The Asia Pacific to witness the highest growth during the forecast period (2021-2026)"

North America is expected to hold the largest share of the global flow cytometry market in 2020 followed by Europe. However, the Asia Pacific is expected to grow at the fastest rate during the forecast period. The increasing participation of China, India, Japan, Australia, and South Korea in flow cytometry-based research; expansion of research infrastructure in the region; and public-private finding aimed towards boosting advance research practices are the key factors responsible for the growth of this market in the Asia Pacific.

Breakdown of primary interviews:

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

  • By Respondents: Supply Side-70% and Demand Side-30%
  • By Designation: Managers-45%, CXOs and Directors-30%, and Executive-25%
  • By Region: North America-40%, Europe-25%, APAC-20%, LATAM-10%,and MEA-5%

The prominent players in the global flow cytometry market include Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Luminex Corporation (US), Agilent Technologies, Inc. (US), Sony Group Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmbH (Germany), Enzo Biochem, Inc. (US), Sysmex Corporation (Japan), bioMerieux S.A. (France), Cytonome/ ST, LLC (US), Sartorius AG (Germany), Cytek Biosciences, Inc. (US), Union Biometrica, Inc. (US), Apogee Flow Systems Ltd. (UK), Stratedigm, Inc. (US), NanoCellect Biomedical, Inc. (US), On-chip Biotechnologies, Co., Ltd. (Japan), NEXCELOM BIOSCIENCE LLC (US), BennuBio Inc. (US), ORFLO Technologies (US), Bay Biosciences Co., Ltd. (Japan), BioLegend, Inc. (US), and CytoBuoy B.V (Netherlands).

Research Coverage

This report studies the flow cytometry market based on technology, product and service, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of market segments with respect to four main regions (and the respective countries in these regions).

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the flow cytometry market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 FLOW CYTOMETRY MARKET SEGMENTATION
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 STAKEHOLDERS
  • 1.6 LIMITATIONS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
      • 2.2.1.1 Key industry insights
    • FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020
    • FIGURE 4 AVERAGE MARKET SIZE ESTIMATION, 2020
    • 2.2.2 USAGE-BASED MARKET ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: FLOW CYTOMETRY MARKET
  • 2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
    • FIGURE 6 FLOW CYTOMETRY MARKET: CAGR PROJECTIONS, 2021-2026
    • FIGURE 7 FLOW CYTOMETRY MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • 2.4 DATA TRIANGULATION METHODOLOGY
    • FIGURE 9 FLOW CYTOMETRY MARKET: DATA TRIANGULATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 10 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 11 FLOW CYTOMETRY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 FLOW CYTOMETRY MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 FLOW CYTOMETRY MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 FLOW CYTOMETRY MARKET OVERVIEW
    • FIGURE 14 TECHNOLOGICAL ADVANCEMENTS IN FLOW CYTOMETRY PRODUCTS TO SUPPORT MARKET GROWTH
  • 4.2 NORTH AMERICA: FLOW CYTOMETRY MARKET SHARE, BY TECHNOLOGY AND COUNTRY (2020)
    • FIGURE 15 CELL-BASED FLOW CYTOMETRY ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN FLOW CYTOMETRY MARKET IN 2020
  • 4.3 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 CANCER DIAGNOSTIC APPLICATIONS WILL CONTINUE TO DOMINATE THE FLOW CYTOMETRY MARKET IN 2026
  • 4.4 FLOW CYTOMETRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 17 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE FLOW CYTOMETRY MARKET FROM 2021 TO 2026

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising global incidence and prevalence of HIV/AIDS and cancer
    • TABLE 1 INCIDENCE OF HIV/AIDS, BY REGION, 2020
    • TABLE 2 GLOBAL CANCER INCIDENCE, 2020 VS. 2040
      • 5.2.1.2 Growing adoption of flow cytometry techniques in research and academia
      • 5.2.1.3 Growing public-private initiatives in immunology and immuno-oncology research
      • 5.2.1.4 Technological advancements
    • TABLE 3 IMPORTANT TECHNOLOGICAL ADVANCEMENTS IN THE FLOW CYTOMETRY MARKET DURING 2018-2021
      • 5.2.1.5 Increasing incorporation of AI platforms in flow cytometry workflow and advancements in flow cytometry software
    • TABLE 4 IMPORTANT SOFTWARE-RELATED ADVANCEMENTS IN THE FLOW CYTOMETRY MARKET DURING 2018-2021
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Significant product costs
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing market presence in the Asia Pacific region
      • 5.2.3.2 Evolving pipeline for stem cell research
    • TABLE 5 NIH-ESTIMATED STEM CELL RESEARCH EXPENDITURE DATA
      • 5.2.3.3 Adoption of recombinant DNA technology for antibody production
      • 5.2.3.4 Evolution of tandem flow cytometry technologies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Complexities related to reagent development
      • 5.2.4.2 Dearth of well-trained and skilled professionals
  • 5.3 IMPACT OF COVID-19 ON THE FLOW CYTOMETRY MARKET
  • 5.4 REGULATORY ASSESSMENT
    • 5.4.1 STRINGENT FDA REQUIREMENTS
    • 5.4.2 STRINGENT ANALYTE-SPECIFIC REAGENT RULE
    • 5.4.3 LACK OF WELL-DEFINED VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS
    • 5.4.4 ABSENCE OF ESTABLISHED LABORATORY-DEVELOPED TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS
    • 5.4.5 GREATER GLOBAL RECOGNITION FOR IVD CE MARK APPROVALS
    • 5.4.6 US REIMBURSEMENT SCENARIO
  • 5.5 PATENT ANALYSIS
    • 5.5.1 NUMBER OF PUBLICATIONS OVER THE LAST 10 YEARS
    • 5.5.2 TOP PATENT OWNERS IN THE LAST 20 YEARS
    • 5.5.3 TOP 10 PLAYERS WITH THE HIGHEST NUMBER OF PATENT APPLICATIONS
    • 5.5.4 LIST OF RECENT PATENTS
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 19 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES
    • 5.6.1 KEY INFLUENCERS
  • 5.7 VALUE CHAIN ANALYSIS
    • FIGURE 20 FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS OF THE FLOW CYTOMETRY MARKET
    • FIGURE 21 ECOSYSTEM ANALYSIS OF THE FLOW CYTOMETRY MARKET
    • 5.8.1 ROLE IN THE ECOSYSTEM
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 6 FLOW CYTOMETRY MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
    • 5.9.2 BARGAINING POWER OF SUPPLIERS
    • 5.9.3 BARGAINING POWER OF BUYERS
    • 5.9.4 THREAT OF SUBSTITUTES
    • 5.9.5 THREAT OF NEW ENTRANTS
  • 5.10 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS
    • FIGURE 22 TRENDS AND DISRUPTIONS IN THE FLOW CYTOMETRY MARKET
  • 5.11 RANGES/SCENARIOS
    • FIGURE 23 DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE FLOW CYTOMETRY MARKET - 2020
  • 5.12 TRADE DATA
    • TABLE 7 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2016-2020 (USD THOUSAND)
    • TABLE 8 EXPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2016-2020 (USD THOUSAND)

6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY

  • 6.1 INTRODUCTION
    • TABLE 9 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
  • 6.2 CELL-BASED FLOW CYTOMETRY
    • 6.2.1 RESEARCH & DEVELOPMENT ON NOVEL THERAPEUTIC AGENTS WILL DRIVE THE GROWTH OF THE CELL-BASED FLOW CYTOMETRY MARKET
    • TABLE 10 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.3 BEAD-BASED FLOW CYTOMETRY
    • 6.3.1 PROCEDURAL ADVANTAGES OF BEAD-BASED FLOW CYTOMETRY HAVE DRIVEN MARKET GROWTH
    • TABLE 11 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2019-2026 (USD MILLION)

7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE

  • 7.1 INTRODUCTION
    • TABLE 12 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
  • 7.2 REAGENTS & CONSUMABLES
    • 7.2.1 CONTINUOUS REQUIREMENT OF FLOW CYTOMETRY REAGENTS BY END USERS TO DRIVE MARKET GROWTH
    • TABLE 13 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 14 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 15 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 16 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 17 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 7.3 INSTRUMENTS
    • TABLE 18 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 19 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION, 2019-2026 (UNITS)
    • TABLE 20 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 21 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (UNITS)
    • TABLE 22 FLOW CYTOMETRY INSTRUMENTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 23 FLOW CYTOMETRY INSTRUMENTS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 24 FLOW CYTOMETRY INSTRUMENTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 25 FLOW CYTOMETRY INSTRUMENTS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 7.3.1 CELL ANALYZERS
    • TABLE 26 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 27 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY REGION, 2019-2026 (UNITS)
    • TABLE 28 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY PRICE RANGE, 2019-2026 (USD MILLION)
    • TABLE 29 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 30 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 31 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 32 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
      • 7.3.1.1 High-range cell analyzers
        • 7.3.1.1.1 Wide adoption of high-range cell analyzers among end users owing to their advantages to drive market growth
    • TABLE 33 HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 7.3.1.2 Mid-range cell analyzers
        • 7.3.1.2.1 Wide availability of compact and high-performance analyzers to support market growth
    • TABLE 34 MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 7.3.1.3 Low-range cell analyzers
        • 7.3.1.3.1 Low-range analyzers find significant adoption among price-sensitive end users
    • TABLE 35 LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.3.2 CELL SORTERS
    • TABLE 36 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 37 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY REGION, 2019-2026 (USD UNITS)
    • TABLE 38 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY PRICE RANGE, 2019-2026 (USD MILLION)
    • TABLE 39 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 40 FLOW CYTOMETRY-BASED CELL SORTERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 41 FLOW CYTOMETRY-BASED CELL SORTERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 42 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY END USER, 2019-2026 (USD MILLION)
      • 7.3.2.1 High-range cell sorters
        • 7.3.2.1.1 High cost and budgetary limitations among end users to restrain market growth to a certain extent
    • TABLE 43 HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 7.3.2.2 Mid-range cell sorters
        • 7.3.2.2.1 Product launches and the cost-efficiency of mid-range sorters have enabled the growth of this market segment
    • TABLE 44 MID-RANGE CELL SORTERS MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 7.3.2.3 Low-range cell sorters
        • 7.3.2.3.1 Small-scale labs and research facilities are the major end user of low-range sorters
    • TABLE 45 LOW-RANGE CELL SORTERS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 SERVICES
    • 7.4.1 REMOTE SERVICES ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE
    • TABLE 46 FLOW CYTOMETRY SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 47 FLOW CYTOMETRY SERVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 48 FLOW CYTOMETRY SERVICES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 49 FLOW CYTOMETRY SERVICES MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 50 FLOW CYTOMETRY SERVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 7.5 SOFTWARE
    • 7.5.1 AVAILABILITY OF A WIDE RANGE OF ANALYSIS SOFTWARE AND ADVANCEMENTS TO DRIVE MARKET GROWTH
    • TABLE 51 FLOW CYTOMETRY SOFTWARE MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 52 FLOW CYTOMETRY SOFTWARE MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 53 FLOW CYTOMETRY SOFTWARE MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 54 FLOW CYTOMETRY SOFTWARE MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 55 FLOW CYTOMETRY SOFTWARE MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 7.6 ACCESSORIES
    • 7.6.1 PROCEDURAL BENEFITS OFFERED BY ACCESSORIES AND AVAILABILITY OF ADVANCED FLOW CYTOMETRY ACCESSORIES ARE THE MAJOR FACTORS SUPPORTING MARKET GROWTH
    • TABLE 56 FLOW CYTOMETRY ACCESSORIES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 57 FLOW CYTOMETRY ACCESSORIES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 58 FLOW CYTOMETRY ACCESSORIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 59 FLOW CYTOMETRY ACCESSORIES MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 60 FLOW CYTOMETRY ACCESSORIES MARKET, BY END USER, 2019-2026 (USD MILLION)

8 FLOW CYTOMETRY MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 61 FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 8.2 RESEARCH APPLICATIONS
    • TABLE 62 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 63 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • 8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY
    • TABLE 64 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
      • 8.2.1.1 Drug discovery
        • 8.2.1.1.1 Growing use of phenotypic cell-based assays in drug discovery to support market growth
    • TABLE 65 FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.1.2 Stem cell research
        • 8.2.1.2.1 Increasing investments in stem cell research to boost the adoption of flow cytometry instruments
    • TABLE 66 FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY REGION, 2019-2026 (USD MILLION)
      • 8.2.1.3 In vitro toxicity testing
        • 8.2.1.3.1 Need to reduce the time and cost of drug development processes to drive market growth
    • TABLE 67 FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY REGION, 2019-2026 (USD MILLION)
    • 8.2.2 IMMUNOLOGY
      • 8.2.2.1 Increasing prevalence of infectious and autoimmune diseases to drive the demand for flow cytometry by research laboratories
    • TABLE 68 FLOW CYTOMETRY MARKET FOR IMMUNOLOGY APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • 8.2.3 CELL SORTING
      • 8.2.3.1 Development of technologically advanced cell sorters to boost the market growth
    • TABLE 69 FLOW CYTOMETRY MARKET FOR CELL SORTING APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • 8.2.4 APOPTOSIS
      • 8.2.4.1 Flow cytometry techniques are used to identify changes occurring during apoptosis
    • TABLE 70 FLOW CYTOMETRY MARKET FOR APOPTOSIS APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • 8.2.5 CELL CYCLE ANALYSIS
      • 8.2.5.1 Chromosomal abnormalities can be detected using flow cytometry
    • TABLE 71 FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • 8.2.6 CELL VIABILITY
      • 8.2.6.1 Cell viability is a key parameter studied using flow cytometry
    • TABLE 72 FLOW CYTOMETRY MARKET FOR CELL VIABILITY APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • 8.2.7 CELL COUNTING
      • 8.2.7.1 Flow cytometry enables easy differentiation of cells via scattering or staining
    • TABLE 73 FLOW CYTOMETRY MARKET FOR CELL COUNTING APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • 8.2.8 OTHER RESEARCH APPLICATIONS
    • TABLE 74 FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 CLINICAL APPLICATIONS
    • TABLE 75 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 76 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • 8.3.1 CANCER DIAGNOSTICS
      • 8.3.1.1 Flow cytometry tools are used to determine the malignancy of a tumor
    • TABLE 77 FLOW CYTOMETRY MARKET FOR CANCER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • 8.3.2 HEMATOLOGY
      • 8.3.2.1 Flow cytometry identifies a wide range of cell surfaces and cytoplasmic antigens
    • TABLE 78 FLOW CYTOMETRY MARKET FOR HEMATOLOGY APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • 8.3.3 AUTOIMMUNE DISEASES
      • 8.3.3.1 Flow cytometry helps in the diagnosis of primary immunodeficiencies
    • TABLE 79 FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASE APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • 8.3.4 ORGAN &TISSUE TRANSPLANTATION
      • 8.3.4.1 The use of flow cytometry to reduce organ rejection rates has contributed to market growth
    • TABLE 80 FLOW CYTOMETRY MARKET FOR ORGAN TRANSPLANTATION APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • 8.3.5 OTHER CLINICAL APPLICATIONS
    • TABLE 81 FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
  • 8.4 INDUSTRIAL APPLICATIONS
    • 8.4.1 A WIDE END-USER BASE WILL DRIVE MARKET GROWTH
    • TABLE 82 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)

9 FLOW CYTOMETRY MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 83 FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.2 ACADEMIC & RESEARCH INSTITUTES
    • 9.2.1 GROWING NUMBER OF RESEARCH PROJECTS THROUGH INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET GROWTH
    • TABLE 84 FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2026 (USD MILLION)
  • 9.3 HOSPITALS & CLINICAL TESTING LABORATORIES
    • 9.3.1 RISING AWARENESS AND DISEASE PREVALENCE HAVE SUSTAINED THE DEMAND FOR FLOW CYTOMETERS IN HOSPITALS & CLINICAL TESTING LABS
    • TABLE 85 FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2019-2026 (USD MILLION)
  • 9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.4.1 INCREASE IN DRUG DISCOVERY ACTIVITIES TO DRIVE MARKET GROWTH
    • TABLE 86 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2026 (USD MILLION)

10 FLOW CYTOMETRY MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 87 FLOW CYTOMETRY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 24 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT
    • TABLE 88 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 89 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 90 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 91 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (UNITS)
    • TABLE 92 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 93 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 94 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 High prevalence of cancer, HIV-AIDS, and autoimmune disorders in the US to drive market growth
    • TABLE 95 US: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 96 US: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 97 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 98 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 99 US: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Ongoing government initiatives to support life science research will boost the demand for flow cytometry products in Canada
    • TABLE 100 CANADA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 101 CANADA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 102 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 103 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 104 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 105 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 106 EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 107 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 108 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (UNITS)
    • TABLE 109 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 110 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 111 EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Strong R&D infrastructure, training, and awareness programs ensure market growth in Germany
    • TABLE 112 GERMANY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 113 GERMANY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 114 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 115 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 116 GERMANY: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Growing acceptance of flow cytometry products for clinical diagnostics in the UK to drive market growth
    • TABLE 117 UK: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 118 UK: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 119 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 120 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 121 UK: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Increasing R&D spending and strong government funding for proteomics and genomics research to fuel the adoption of flow cytometry
    • TABLE 122 FRANCE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 123 FRANCE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 124 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 125 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 126 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Increasing geriatric population and growing life science research activities to drive market demand in Italy
    • TABLE 127 ITALY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 128 ITALY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 129 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 130 ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 131 ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Growing focus on cancer diagnosis is increasing the use of flow cytometry products in Spain
    • TABLE 132 SPAIN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 133 SPAIN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 134 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 135 SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 136 SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 137 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 138 REST OF EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 139 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 140 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 141 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 25 ASIA PACIFIC: FLOW CYTOMETRY MARKET SNAPSHOT
    • TABLE 142 APAC: FLOW CYTOMETRY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 143 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 144 ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 145 ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (UNITS)
    • TABLE 146 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 147 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 148 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Growing flow cytometry-based research activities to drive market growth in Japan
    • TABLE 149 JAPAN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 150 JAPAN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 151 JAPAN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 152 JAPAN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 153 JAPAN: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 High incidence of target diseases and growing presence of global players to drive market growth in China
    • TABLE 154 CHINA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 155 CHINA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 156 CHINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 157 CHINA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 158 CHINA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Increasing pharma R&D and strong government funding in the biotechnology industry to drive market growth in India
    • TABLE 159 INDIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 160 INDIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 161 INDIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 162 INDIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 163 INDIA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Rising cancer prevalence and increasing government initiatives to drive market growth in Australia
    • TABLE 164 AUSTRALIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 165 AUSTRALIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 166 AUSTRALIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 167 AUSTRALIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 168 AUSTRALIA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Strong government support for the biotechnology industry and rising awareness of flow cytometry to drive the South Korean market
    • TABLE 169 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 170 SOUTH KOREA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 171 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 172 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 173 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 174 ROAPAC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 175 ROAPAC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 176 ROAPAC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 177 ROAPAC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 178 ROAPAC: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 179 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 180 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 181 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 182 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (UNITS)
    • TABLE 183 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 184 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 185 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Brazil dominates the Latin American flow cytometry market
    • TABLE 186 BRAZIL: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 187 BRAZIL: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 188 BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 189 BRAZIL: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 190 BRAZIL: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Favorable trade agreements to support imports and accessibility to flow cytometry products in Mexico
    • TABLE 191 MEXICO: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 192 MEXICO: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 193 MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 194 MEXICO: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 195 MEXICO: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 196 ROLA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 197 ROLA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 198 ROLA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 199 ROLA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 200 ROLA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS IN THE RESEARCH SECTOR TO DRIVE MARKET GROWTH
    • TABLE 201 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 202 MIDDLE EAST & AFRICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 203 MIDDLE EAST & AFRICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (UNITS)
    • TABLE 204 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 205 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 206 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY END USER, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
    • FIGURE 26 FLOW CYTOMETRY MARKET: STRATEGIES ADOPTED
  • 11.3 MARKET SHARE ANALYSIS
    • FIGURE 27 FLOW CYTOMETRY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
    • TABLE 207 FLOW CYTOMETRY MARKET: DEGREE OF COMPETITION
  • 11.4 COMPANY EVALUATION QUADRANT
    • 11.4.1 STARS
    • 11.4.2 EMERGING LEADERS
    • 11.4.3 PERVASIVE PLAYERS
    • 11.4.4 PARTICIPANTS
    • FIGURE 28 FLOW CYTOMETRY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
  • 11.5 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2020)
    • 11.5.1 PROGRESSIVE COMPANIES
    • 11.5.2 STARTING BLOCKS
    • 11.5.3 RESPONSIVE COMPANIES
    • 11.5.4 DYNAMIC COMPANIES
    • FIGURE 29 FLOW CYTOMETRY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2020
  • 11.6 COMPETITIVE BENCHMARKING
    • 11.6.1 COMPANY FOOTPRINT
    • TABLE 208 COMPANY PRODUCT FOOTPRINT
    • TABLE 209 COMPANY REGIONAL FOOTPRINT
  • 11.7 COMPETITIVE SCENARIO AND TRENDS
    • 11.7.1 PRODUCT LAUNCHES
    • TABLE 210 FLOW CYTOMETRY MARKET: PRODUCT LAUNCHES, JANUARY 2018-JULY 2021
    • 11.7.2 DEALS
    • TABLE 211 FLOW CYTOMETRY MARKET: DEALS, JANUARY 2018-JULY 2021

12 COMPANY PROFILES

  • 12.1 KEY COMPANIES

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**

    • 12.1.1 BECTON, DICKINSON AND COMPANY
    • TABLE 212 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
    • TABLE 213 BECTON, DICKINSON AND COMPANY: PRODUCT/SERVICE OFFERINGS
    • TABLE 214 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS
    • 12.1.2 DANAHER CORPORATION
    • TABLE 215 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
    • TABLE 216 DANAHER CORPORATION: PRODUCT/SERVICE OFFERINGS
    • TABLE 217 DANAHER CORPORATION: PRODUCT LAUNCHES AND ENHANCEMENTS
    • TABLE 218 DANAHER CORPORATION: DEALS
    • 12.1.3 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 219 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
    • FIGURE 32 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020)
    • TABLE 220 THERMO FISHER SCIENTIFIC, INC.: PRODUCT/SERVICE OFFERINGS
    • TABLE 221 THERMO FISHER SCIENTIFIC, INC.: PRODUCT LAUNCHES AND ENHANCEMENTS
    • TABLE 222 THERMO FISHER SCIENTIFIC, INC.: DEALS
    • 12.1.4 AGILENT TECHNOLOGIES, INC.
    • TABLE 223 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
    • FIGURE 33 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020)
    • TABLE 224 AGILENT TECHNOLOGIES, INC.: PRODUCT OFFERINGS
    • TABLE 225 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES
    • TABLE 226 AGILENT TECHNOLOGIES, INC.: DEALS
    • 12.1.5 SONY BIOTECHNOLOGY INC. (A SUBSIDIARY OF SONY GROUP CORPORATION)
    • TABLE 227 SONY GROUP CORPORATION: BUSINESS OVERVIEW
    • FIGURE 34 SONY GROUP CORPORATION: COMPANY SNAPSHOT (2020)
    • TABLE 228 SONY BIOTECHNOLOGY INC.: PRODUCT/SERVICE OFFERINGS
    • 12.1.6 BIO-RAD LABORATORIES, INC.
    • TABLE 229 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 35 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
    • TABLE 230 BIO-RAD LABORATORIES, INC.: PRODUCT/SERVICE OFFERINGS
    • TABLE 231 BIO-RAD LABORATORIES, INC.: DEALS
    • 12.1.7 MILTENYI BIOTEC
    • TABLE 232 MILTENYI BIOTEC: BUSINESS OVERVIEW
    • TABLE 233 MILTENYI BIOTEC: PRODUCT/SERVICE OFFERINGS
    • TABLE 234 MILTENYI BIOTEC: PRODUCT LAUNCHES
    • 12.1.8 ENZO BIOCHEM, INC.
    • TABLE 235 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW
    • FIGURE 36 ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2020)
    • TABLE 236 ENZO BIOCHEM, INC.: PRODUCT OFFERINGS
    • 12.1.9 SYSMEX CORPORATION
    • TABLE 237 SYSMEX CORPORATION: BUSINESS OVERVIEW
    • FIGURE 37 SYSMEX CORPORATION: COMPANY SNAPSHOT (2020)
    • TABLE 238 SYSMEX CORPORATION: PRODUCT/SERVICE OFFERINGS
    • TABLE 239 SYSMEX CORPORATION: PRODUCT LAUNCHES
    • 12.1.10 BIOMERIEUX SA
    • TABLE 240 BIOMERIEUX SA: BUSINESS OVERVIEW
    • FIGURE 38 BIOMERIEUX SA: COMPANY SNAPSHOT (2020)
    • TABLE 241 BIOMERIEUX SA: PRODUCT/SERVICE OFFERINGS
    • 12.1.11 CYTONOME/ST, LLC.
    • TABLE 242 CYTONOME/ST, LLC: BUSINESS OVERVIEW
    • TABLE 243 CYTONOME/ST, LLC: PRODUCT OFFERINGS
    • 12.1.12 SARTORIUS AG
    • TABLE 244 SARTORIUS AG: BUSINESS OVERVIEW
    • FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2020)
    • TABLE 245 SARTORIUS AG: PRODUCT OFFERINGS
    • TABLE 246 SARTORIUS AG: PRODUCT LAUNCHES/UPGRADES
    • 12.1.13 CYTEK BIOSCIENCES
    • TABLE 247 CYTEK BIOSCIENCES: BUSINESS OVERVIEW
    • TABLE 248 CYTEK BIOSCIENCES: PRODUCT/SERVICE OFFERINGS
    • TABLE 249 CYTEK BIOSCIENCES: PRODUCT LAUNCHES/APPROVALS
    • TABLE 250 CYTEK BIOSCIENCES: DEALS
    • TABLE 251 CYTEK BIOSCIENCES: OTHER DEVELOPMENTS
    • 12.1.14 UNION BIOMETRICA, INC.
    • TABLE 252 UNION BIOMETRICA, INC.: BUSINESS OVERVIEW
    • TABLE 253 UNION BIOMETRICA, INC.: PRODUCT/SERVICE OFFERINGS
    • 12.1.15 LUMINEX CORPORATION
    • TABLE 254 LUMINEX CORPORATION: BUSINESS OVERVIEW
    • FIGURE 40 LUMINEX CORPORATION: COMPANY SNAPSHOT (2020)
    • TABLE 255 LUMINEX CORPORATION: PRODUCT/SERVICE OFFERINGS
    • TABLE 256 LUMINEX CORPORATION: DEALS
  • 12.2 START-UP PLAYERS
    • 12.2.1 APOGEE FLOW SYSTEMS LTD.
    • TABLE 257 APOGEE FLOW SYSTEMS LTD.: BUSINESS OVERVIEW
    • TABLE 258 APOGEE FLOW SYSTEMS LTD.: PRODUCT/SERVICE OFFERINGS
    • TABLE 259 APOGEE FLOW SYSTEMS LTD.: PRODUCT LAUNCHES/UPGRADES
    • 12.2.2 STRATEDIGM, INC.
    • TABLE 260 STRATEDIGM, INC.: BUSINESS OVERVIEW
    • TABLE 261 STRATEDIGM, INC.: PRODUCT/SERVICE OFFERINGS
    • TABLE 262 STRATEDIGM, INC.: PRODUCT LAUNCHES/UPGRADES
    • TABLE 263 STRATEDIGM, INC.: DEALS
    • 12.2.3 NANOCELLECT BIOMEDICAL, INC.
    • 12.2.4 ON-CHIP BIOTECHNOLOGIES CO., LTD.
    • 12.2.5 NEXCELOM BIOSCIENCE LLC.
    • 12.2.6 BENNUBIO INC.
    • 12.2.7 ORFLO TECHNOLOGIES
    • 12.2.8 BAY BIOSCIENCE CO., LTD.
    • 12.2.9 CYTOBUOY B.V.
    • 12.2.10 BIOLEGEND, INC.
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS